TAX INVERSION RULES HALT SHIRE ABBVIE TIE UP

摘要

Plans to create one of the world's biggest pharmaceutical companies have fallen foul of the US government's tough new stance on corporate tax inversions. US pharma giant AbbVie has abandoned its $54bn (£34bn) takeover of UK drugs manufacturer Shire on the grounds that the deal will no longer deliver the anticipated tax benefits.